{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:16:13Z","timestamp":1779297373090,"version":"3.51.4"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibiotic resistance significantly impacts the success of Helicobacter pylori eradication. This study aimed to evaluate the antibiotic resistance patterns among a Chinese Yi ethnic population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Gastric biopsy specimens were collected from Chinese Yi patients undergoing endoscopy at 2 hospitals for H. pylori isolation and pathological assessment. Antimicrobial susceptibility testing (AST) was performed for amoxicillin (AML), tetracycline (TET), clarithromycin (CLR), metronidazole (MTZ), levofloxacin (LEV), rifampicin (RIF), and furazolidone (FZD) using Etest or disk diffusion. Univariate and multivariate logistic analysis were used to identify factors associated with antimicrobial resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 501 gastric specimens, 262 H. pylori strains were isolated (52.3% culture rate). Of the 262 H. pylori-positive patients (110 men and 152 women, mean age 40.7 years), endoscopic findings revealed that 129 (49.2%) had chronic atrophic gastritis, 40 (15.3%) had peptic ulcers, and 2 (0.8%) had gastric malignancy. Pathological analysis revealed a high prevalence of moderate-to-severe chronic gastric atrophy (75.6%), intestinal metaplasia (14.7%), and dysplasia (0.8%). The overall resistance rates were the following: AML (0.0%), TET (0.4%), CLR (22.9%), MTZ (86.3%), LEV (39.7%), RIF (52.7%), and FZD (0.0%). Multi-drug resistance was observed in 32.1% of the strains. Age (for CLR, MTZ, and LEV) and female gender (for MTZ) were independent factors associated with antimicrobial resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chronic gastric atrophy is highly prevalent among Yi patients, emphasizing the need for endoscopic screening and prompt H. pylori eradication to prevent gastric cancer. Due to high resistance, CLR, MTZ, and LEV should not be used empirically. In contrast, TET, AML, and FZD show negligible resistance, treatment regimens based on these antibiotics are likely to be effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf411","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:40:32Z","timestamp":1753962032000},"page":"S359-S366","source":"Crossref","is-referenced-by-count":2,"title":["Antimicrobial Resistance of\n                    <i>Helicobacter pylori<\/i>\n                    Among Chinese Yi Population"],"prefix":"10.1093","volume":"232","author":[{"given":"Jinzhi","family":"Zhang","sequence":"first","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, First People's Hospital of Liangshan Yi Autonomous Prefecture , Xichang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Song","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghua","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Zhaojue County People's Hospital , Xichang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhaojue County People's Hospital , Xichang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, First People's Hospital of Liangshan Yi Autonomous Prefecture , Xichang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Shen","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Infection, West China Tianfu Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9705-4010","authenticated-orcid":false,"given":"Alfred C Y","family":"Tay","sequence":"additional","affiliation":[{"name":"Helicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Diseases Research and Training, University of Western Australia , Nedlands ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J","family":"Marshall","sequence":"additional","affiliation":[{"name":"Helicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Diseases Research and Training, University of Western Australia , Nedlands ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3528-0448","authenticated-orcid":false,"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]},{"name":"Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"2025112010501856600_jiaf411-B1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112010501856600_jiaf411-B2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"9","key":"2025112010501856600_jiaf411-B3","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"2025112010501856600_jiaf411-B4","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"2025112010501856600_jiaf411-B5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/pathogens10091099","article-title":"Helicobacter pylori-induced inflammation: possible factors modulating the risk of gastric cancer","volume":"10","author":"Kumar","year":"2021","journal-title":"Pathogens"},{"key":"2025112010501856600_jiaf411-B6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/apt.14424","article-title":"Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication\u2014a prospective study for up to 10 years","volume":"47","author":"Hwang","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112010501856600_jiaf411-B7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gutjnl-2020-322200","article-title":"Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands","volume":"70","author":"Chiang","year":"2021","journal-title":"Gut"},{"key":"2025112010501856600_jiaf411-B8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","article-title":"Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up","volume":"163","author":"Yan","year":"2022","journal-title":"Gastroenterology"},{"key":"2025112010501856600_jiaf411-B9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"Acg clinical guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2025112010501856600_jiaf411-B10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"2025112010501856600_jiaf411-B11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"2025112010501856600_jiaf411-B12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1473-3099(17)30005-1","article-title":"How long until routine Helicobacter pylori antimicrobial susceptibility testing?","volume":"17","author":"Montes","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025112010501856600_jiaf411-B13","first-page":"687","article-title":"Epidemiological investigation of Helicobacter pylori infection and analysis of related influencing factors in adult Yi population in Leshan area","volume":"26","author":"Deng","year":"2018","journal-title":"Chin J Integr Traditional and Western Med Gastroenterol"},{"key":"2025112010501856600_jiaf411-B14","first-page":"265","article-title":"Epidemiological survey of Helicobacter pylori infection in the natural population of China","volume":"15","author":"Zhang","year":"2010","journal-title":"Mod Dig Interv Dx"},{"key":"2025112010501856600_jiaf411-B15","first-page":"1124","article-title":"Meta-analysis of Helicobacter pylori epidemiology in China from 2012 to 2022","volume":"39","author":"Zhu","year":"2023","journal-title":"J Prevent Med Info"},{"key":"2025112010501856600_jiaf411-B16","first-page":"1112","article-title":"A single-center analysis of clinical and pathological features of gastric cancer patients in Yi and Han ethnic groups","volume":"30","author":"Zhang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112010501856600_jiaf411-B17","first-page":"164","article-title":"Analysis of gastric cancer incidence in high mountain Yi areas","volume":"5","author":"Pan","year":"2012","journal-title":"Clin Rat Med"},{"key":"2025112010501856600_jiaf411-B18","first-page":"521","article-title":"Analysis of endoscopic findings in 2219 cases of three common gastric diseases in Liangshan Yi area","volume":"06","author":"Zhang","year":"2000","journal-title":"Sichuan Med J"},{"key":"2025112010501856600_jiaf411-B19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"2025112010501856600_jiaf411-B20","author":"Zhang","year":"2021"},{"key":"2025112010501856600_jiaf411-B21","doi-asserted-by":"crossref","first-page":"e12703","DOI":"10.1111\/hel.12703","article-title":"Re-assessment of the disk diffusion technique for routine antimicrobial susceptibility testing for Helicobacter pylori","volume":"25","author":"Tang","year":"2020","journal-title":"Helicobacter"},{"key":"2025112010501856600_jiaf411-B22","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/hel.12873","article-title":"Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing","volume":"27","author":"Li","year":"2022","journal-title":"Helicobacter"},{"key":"2025112010501856600_jiaf411-B23","volume-title":"Performance stabdards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2025","edition":"35 ed"},{"key":"2025112010501856600_jiaf411-B24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1590\/S1517-83822014000400039","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion","volume":"45","author":"Ogata","year":"2014","journal-title":"Brazilian J Microbiol"},{"key":"2025112010501856600_jiaf411-B25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance\u2014from biology to clinical implications","volume":"18","author":"Tshibangu-Kabamba","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025112010501856600_jiaf411-B26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2024.11.001","article-title":"Aga clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States","volume":"168","author":"Shah","year":"2025","journal-title":"Gastroenterology"},{"key":"2025112010501856600_jiaf411-B27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12876-023-02662-1","article-title":"Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"2025112010501856600_jiaf411-B28","doi-asserted-by":"crossref","first-page":"e946516","DOI":"10.12659\/MSM.946516","article-title":"Gastrointestinal system endoscopy and pathological findings in non-dialysis chronic kidney disease: a single-center study","volume":"31","author":"Usta","year":"2025","journal-title":"Med Sci Monit"},{"key":"2025112010501856600_jiaf411-B29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4166\/kjg.2024.063","article-title":"Histopathological features of chronic gastritis and its association with Helicobacter pylori infection","volume":"84","author":"Shukla","year":"2024","journal-title":"Korean J Gastroenterol"},{"key":"2025112010501856600_jiaf411-B30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1097\/CM9.0000000000002884","article-title":"Antibiotic resistance in Helicobacter pylori among children and adolescents in East Asia: a systematic review and meta-analysis","volume":"137","author":"Zhou","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"2025112010501856600_jiaf411-B31","first-page":"397","article-title":"Therapeutic uses of metronidazole and its side effects: an update","volume":"23","author":"Hern\u00e1ndez Ceruelos","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025112010501856600_jiaf411-B32","doi-asserted-by":"crossref","first-page":"e12485","DOI":"10.1111\/hel.12485","article-title":"Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance","volume":"23","author":"Long","year":"2018","journal-title":"Helicobacter"},{"key":"2025112010501856600_jiaf411-B33","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy","volume":"64","author":"Zhang","year":"2015","journal-title":"Gut"},{"key":"2025112010501856600_jiaf411-B34","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","article-title":"Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community","volume":"70","author":"Megraud","year":"2021","journal-title":"Gut"},{"key":"2025112010501856600_jiaf411-B35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112010501856600_jiaf411-B36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cmi.2019.06.007","article-title":"Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018","volume":"26","author":"Bluemel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025112010501856600_jiaf411-B37","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3748\/wjg.v21.i9.2786","article-title":"Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2025112010501856600_jiaf411-B38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12866-022-02613-y","article-title":"Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet autonomous region, China","volume":"22","author":"Tang","year":"2022","journal-title":"BMC Microbiol"},{"key":"2025112010501856600_jiaf411-B39","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2217\/fmb-2020-0206","article-title":"Primary antibiotic resistance of Helicobacter pylori among a Chinese Tibetan population","volume":"15","author":"Tang","year":"2020","journal-title":"Future Microbiol"},{"key":"2025112010501856600_jiaf411-B40","first-page":"311","article-title":"Analysis of the epidemiological characteristics of tuberculosis in meigu county, Liangshan Yi autonomous prefecture, sichuan province from 2019 to 2023","volume":"5","author":"Le","year":"2024","journal-title":"J Tuberculosis Pulmonary Dis"},{"issue":"Suppl 5","key":"2025112010501856600_jiaf411-B41","doi-asserted-by":"crossref","first-page":"S479","DOI":"10.1093\/infdis\/jiac417","article-title":"The inappropriateness of using rifampicin E-test to predict rifabutin resistance in Helicobacter pylori","volume":"226","author":"Yang","year":"2022","journal-title":"J Infect Dis"},{"key":"2025112010501856600_jiaf411-B42","doi-asserted-by":"crossref","first-page":"107325","DOI":"10.1016\/j.ijantimicag.2024.107325","article-title":"Antibiotic resistance of Helicobacter pylori in mainland China: a focus on geographic differences through systematic review and meta-analysis","volume":"64","author":"Zeng","year":"2024","journal-title":"Int J Antimicrobial Agents"},{"key":"2025112010501856600_jiaf411-B43","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s00431-022-04456-1","article-title":"Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China","volume":"181","author":"Geng","year":"2022","journal-title":"Eur J Pediatr"},{"key":"2025112010501856600_jiaf411-B44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cmi.2016.06.003","article-title":"Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods","volume":"22","author":"Ducournau","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2025112010501856600_jiaf411-B45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/microorganisms12030429","article-title":"Minocycline\/amoxicillin-based bismuth quadruple therapy for Helicobacter pylori eradication: a pilot study","volume":"12","author":"You","year":"2024","journal-title":"Microorganisms"},{"key":"2025112010501856600_jiaf411-B46","doi-asserted-by":"crossref","first-page":"17562848241299734","DOI":"10.1177\/17562848241299734","article-title":"The efficacy and safety of a simple 14-day vonoprazan-minocycline dual therapy for Helicobacter pylori eradication: a retrospective pilot study","volume":"17","author":"Wang","year":"2024","journal-title":"Therap Adv Gastroenterol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/Supplement_4\/S359\/65408941\/jiaf411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/Supplement_4\/S359\/65408941\/jiaf411.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:50:40Z","timestamp":1763653840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/Supplement_4\/S359\/8329324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":46,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2025,11,20]]},"published-print":{"date-parts":[[2025,11,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf411","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,15]]},"published":{"date-parts":[[2025,11,15]]}}}